Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics has issued a corrected investor caution notice disclosing that, in accordance with the revised corporate spin-off schedule (August 22, 2025), the adjusted final trading day for its stock futures/options has been postponed to October 29, 2025, and the non-listing date for new contract months has been updated to October 17, 2025.
📊 [Key Disclosure Details & Financial Figures]
- Original Filing & Submission Date: Investor Caution Notice on Stock Futures and Options (Submitted on May 29, 2025)
- Reason for Correction: Reflecting the corrected corporate spin-off disclosure of Samsung Biologics Co., Ltd. (August 22, 2025)
- Key Correction Items:
- Target Contracts (Stock Futures & Options):
- (Before) Oct ’25*, Nov ’25*, Dec ’25, Mar ’26, Jun ’26*, Sep ’26* (*Scheduled for listing)
- (After) Nov ’25, Dec ’25, Jan ’26*, Mar ’26, Jun ’26, Sep ’26* (*Scheduled for listing)
- Adjusted Final Trading Day:
- (Before) September 26, 2025 (Trading day immediately preceding trading suspension)
- (After) October 29, 2025 (Trading day immediately preceding trading suspension)
- Non-listing Reference Date for New Expiry Months:
- (Before) Following the shareholder approval date for spin-off (September 16, 2025)
- (After) Following the shareholder approval date for spin-off (October 17, 2025)
- Target Contracts (Stock Futures & Options):
- Governing Rules: Articles 27, 37, and 155 of the Derivatives Market Business Regulations and Articles 11, 19, and 164 of its Enforcement Rules
- Other Reference Items:
- Matters regarding the new listing of Samsung Biologics stock futures and options will be announced at a later date.
- The above plan is subject to change depending on the schedule and outcome of the general meeting of shareholders.
- Related Disclosures:
- May 22, 2025: Decision on Corporate Spin-off
- August 22, 2025: Decision on Corporate Spin-off
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verifying Adjusted Final Trading Day and Derivative Market Measures
This correction disclosure updates the schedule for derivative market measures—including postponing the adjusted final trading day to October 29, 2025, and updating the non-listing reference date to October 17, 2025—to align with Samsung Biologics’ revised spin-off timeline.
Monitoring the application of updated market measures and tracking official announcements following the revised shareholder meeting date (October 17, 2025) is essential.
Relevant developments can be verified in future market notices issued by the Korea Exchange (KRX) and subsequent disclosures regarding the shareholder meeting outcome.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
